Cell-directed aptamer therapeutic targeting for cancers including those within the central nervous system-Reference-Cited by-同舟云学术

Cell-directed aptamer therapeutic targeting for cancers including those within the central nervous system

Published:2022-04-13 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Wei Jun¹,Song Renduo²,Sabbagh Aria²,Marisetty Anantha²,Shukla Neal²,Fang Dexing²,Najem Hinda³⁴,Ott Martina²,Long James⁵,Zhai Lijie³⁴,Lesniak Maciej S.³⁴,James Charles David³⁴,Platanias Leonidas⁶⁷,Curran Michael¹,Heimberger Amy B.³⁴^ORCID

Affiliation:

1. Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

2. Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

3. Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

4. Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA

5. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

6. Robert H. Lurie Comprehensive Cancer Center and Division of Hematology-Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

7. Department of Medicine, Jesse Brown Veterans Affairs Medical Center, Chicago, IL, USA

Funder

Ben and Catherine Ivy Foundation

Provost Retention Funds

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2062827

Reference41 articles.

1. Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia